Member access

4-Traders Homepage  >  Shares  >  Xetra  >  Bayer AG    BAYN   DE000BAY0017


SummaryQuotesChart AnalysisNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

Bayer Stops Sale of Glucose Meter Business

01/09/2013 | 06:07am US/Eastern

By Hendrik Varnholt

FRANKFURT--German pharmaceutical company Bayer AG (>> Bayer AG) will retain its blood glucose meter business, a spokeswoman said Wednesday, confirming a Bloomberg report.

Bayer had put up the unit for sale and had been in talks with French peer Sanofi SA (>> SANOFI) about a deal which could have been valued at around $1.5 billion, people familiar with the matter told Dow Jones Newswires in December.

"We have evaluated several options and decided to retain it," Bayer HealthCare chief Joerg Reinhardt said about the glucose meter business, according to Bloomberg.

Natali Schwab, Eyk Henning and Dana Cimilluca contributed to this story.

Write to Hendrik Varnholt at

Subscribe to WSJ:

Stocks mentioned in the article : Bayer AG, SANOFI
React to this article
Latest news on BAYER AG
01/23 BAYER CROPSCIENCE : Flupyradifurone; Pesticide Tolerances
01/23 Dealmakers in Davos see more M&A despite geopolitical risks
01/21 BAYER : MaterialScience AG - Countdown for unparalleled flight, high-tech materi..
01/21 BAYER CROPSCIENCE : New insecticide Sivanto registered in the USA
01/20 BAYER : CropScience offers growers innovative solution with outstanding safety p..
01/17 BAYER : Church ceiling is inspiration for 'hare trio' ruby ring
01/15 BAYER : foundation supports the voluntary efforts of employees on behalf of soci..
01/15 BAYER : MaterialScience optimizes polyurethane systems for automotive clearcoats..
01/15 BAYER : Efficient application of flexible floor coatings -- New raw materials fr..
01/15 BAYER : New milestones in polyurethanes
Duration : Period :
Bayer AG Technical Analysis Chart | BAYN | DE000BAY0017 | 4-Traders
Income Statement Evolution
More Financials
Dynamic quotes